top of page

Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial

Product details

Registration number: SIN16899P

Classification: Prescription Only

Active ingredients:

  • Fosnetupitant Chloride Hydrochloride equivalent to Fosnetupitant
  • Palonosetron hydrochloride equivalent to Palonosetron

Strength:

  • 235mg/vial
  • 0.25 mg/vial

Dosage form: INFUSION, SOLUTION CONCENTRATE

Route: INTRAVENOUS

Registrant: JUNIPER BIOLOGICS PTE LTD

ATC code: A04AA55

HSA approval date: 28 November 2023

Manufacturer(s): Simtra Deutschland GmbH

Manufacturing country/countries: GERMANY

What are the HSA registration number and classification for Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16899P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • Fosnetupitant Chloride Hydrochloride equivalent to Fosnetupitant
  • Palonosetron hydrochloride equivalent to Palonosetron

Strength:

  • 235mg/vial
  • 0.25 mg/vial

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial?

According to the HSA dataset updated 7 August 2026:

Dosage form: INFUSION, SOLUTION CONCENTRATE

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial?

According to the HSA dataset updated 7 August 2026:

Registrant: JUNIPER BIOLOGICS PTE LTD

Source for this answer

Which manufacturers and countries are listed for Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Simtra Deutschland GmbH

Manufacturing country/countries: GERMANY

Source for this answer

Where can I look up Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16899P or the exact product name Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial. The general register link does not preselect this product.

Source for this answer

What are the source dates for this Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this Akynzeo® IV Concentrate for Solution for Infusion 235 mg/0.25 mg/vial record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16899P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page